The Pharmacological Treatment Options for Pediatric Migraine: An Evidence-Based Appraisal

NeuroRx

Volumn 3, Issue 2, 2006, Pages 181-191

  Lewis, Donald W ^a   Winner, Paul ^a  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

Author keywords

adolescents; children; Migraine; treatment

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYPROHEPTADINE; ETIRACETAM; FLUNARIZINE; FLUOXETINE; GABAPENTIN; IBUPROFEN; METOPROLOL; NADOLOL; NAPROXEN; NIMODIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIZOTIFEN; PROPRANOLOL; RIZATRIPTAN; SUMATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL; ZOLMITRIPTAN;

ABDOMINAL DISCOMFORT; ANOREXIA; ANXIETY; APPETITE; ARTICLE; ATAXIA; ATRIOVENTRICULAR BLOCK; BURNING SENSATION; CAPILLARY RESISTANCE; CHEST TIGHTNESS; CLINICAL TRIAL; COGNITIVE DEFECT; DEPRESSION; DIAGNOSTIC TEST; DISABILITY; DISEASE CLASSIFICATION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSGEUSIA; DYSTONIA; EVIDENCE BASED PRACTICE; EXTRAPYRAMIDAL SYNDROME; FATIGUE; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HAIR LOSS; HEART PALPITATION; HEAT; HUMAN; HYPNOSIS; HYPOTENSION; INSOMNIA; IRRITABILITY; LIFESTYLE; LIVER TOXICITY; MENSTRUAL CYCLE; MIGRAINE; NAUSEA; NEPHROLITHIASIS; OCULOGYRIC CRISIS; OPEN STUDY; OVARY CYST; PARESTHESIA; PEDIATRICS; PHOTOPHOBIA; PRESSURE; PREVALENCE; QUALITY OF LIFE; REYE SYNDROME; SEDATION; SENSORY DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; STATISTICAL SIGNIFICANCE; STOMACH DISEASE; STRESS; TACHYCARDIA; TASTE DISORDER; THORAX PAIN; TINNITUS; TRANSFORMED MIGRAINE; TREATMENT PLANNING; TREMOR; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA; ADOLESCENT; CHILD; EVIDENCE BASED MEDICINE; REVIEW;

ADOLESCENT; CHILD; EVIDENCE-BASED MEDICINE; HUMANS; MIGRAINE DISORDERS;

EID: 33646142299     PISSN: 15455343     EISSN: 15455351     Source Type: Journal    
DOI: 10.1016/j.nurx.2006.01.002     Document Type: Article

References (38)

1. Lewis D., Ashwal S., Hershey A., et al. Practice Parameter. Pharmacological treatment of migraine headache in children and adolescents. Neurology 63 (2004) 2215-2224
2. Valquist B. Migraine in children. Internat Arch Allergy 7 (1955) 348-355
3. Prensky A.L., and Sommer D. Diagnosis and treatment of migraine in children. Neurology 29 (1979) 506-510
4. Oleson J. The international classification of headache disorders. Cephalalgia 24 suppl. 1 (2004) 1-160
5. Silberstein S.D. Practice Parameter. Evidence-based guidelines for migraine headache (an evidence-based review). Neurology 55 (2000) 754-762
6. Powers S., Patton S., Hommell K., and Hershey A. Quality of life in paediatric migraine. characterization of age-related effects using PedsQL 4.0. Cephalalgia 24 (2004) 120-127
7. Hamalainen M., Hoppu K., Valkeila E., et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children. a double-blind, randomized, placebo-controlled, crossover study. Neurology 48 (1997) 102-107
8. Lewis D., Kellstein D., Burke B., et al. Children's ibuprofen suspension for the acute treatment of migraine headache. Headache 42 (2002) 780-786
9. Hamalainen M. Sumatriptan for migraine attacks in children. A randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently that adults? Neurology 48 (1997) 1100-1103
10. Winner P., Prensky A., Linder S., et al. Adolescent migraine. efficacy and safety of sumatriptan tablets. Journal of Neurological Sciences 150 suppl (1997) S172
11. Winner P., Rothner A.D., Saper J., et al. Sumatriptan nasal spray in the treatment of acute migraine in adolescent. Pediatrics 106 (2000) 989-997
12. Winner P., Rothner A., Webster C., and Ames M. Overall efficacy of Sumatriptan Nasal Spray in Adolescent Migraineurs. Pooled Results from US Placebo-Controlled Trials. Headache 44 (2004) 465
13. Linder S.L. Subcutaneous Sumatriptan in the Clinical Setting. The first 50 consecutive patients with acute migraine in the pediatric neurology office practice. Headache 36 (1996) 419-422
14. Winner P., Lewis D., Visser W.H., et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents. a randomized, double-blind placebo-controlled study. Headache 42 (2002) 49-55
15. Linder S.L., and Dowson A.J. Zolmitriptan provides effective migraine relief in ado-lescents. Int J Clin Prac 54 (2000) 466-469
16. Lewis D., Winner P., Hershey A., et al. Zolmitriptan 5 mg nasal spray is effective and well-tolerated in the acute treatment of adolescent migraine. European J of Neuro 12 Suppl 12 (2005) 206
17. Lewis D., Diamond S., Scott D., et al. Prophylactic treatment of pediatric migraine. Headache 44 (2004) 230-237
18. Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurologica 50 (1974) 109-115
19. Forsythe W.I., Gillies D., and Sills M.A. Propranolol (Inderal) in the treatment of childhood migraine. Dev Med Child Neuro 26 (1984) 737-741
20. Olness K., MacDonald J.T., and Uden D.L. Comparison of Self-Hypnosis and Propranolol in the Treatment of Juvenile Classic Migraine. Pediatrics 79 (1987) 593-597
21. Noronha M.J. Double-blind randomized cross-over trial of timolol in migraine prophylaxis in children. Cephalalgia 5 Suppl. 3 (1985) 174-175
22. Hershey A.D., Powers S.W., Bentti A.L., and deGrauw T.J. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 40 (2000) 539-549
23. Battistella P., Ruffilla R., Baldin L., et al. Trazodone prophylaxis of childhood migraine. A double blind placebo controlled cross-over study. Giornale di Neuropsichiatria Dell 'Eta Evolutiva 13 (1993) 179-186
24. Gillies D., Sills M., and Forsythe I. Pizotifen (Sanomigran) in childhood migraine. A double-blind placebo controlled trial. European Neurology 25 (1986) 32-35
25. Storey J.R., Calder C.S., Hart D.E., and Potter D.L. Topiramate in migraine prevention. A double-blind, placebo-controlled study. Headache 41 (2001) 968-975
26. Hershey A.D., Powers S.W., Vockell A.L., et al. Effectiveness of topiramate in the prevention of childhood headache. Headache 42 (2002) 810-818
27. Younkin D.P. Topiramate in the treatment of pediatric migraine. Headache 42 (2002) 456
28. Ferreia J., Garcia N., and Pedreira L. A case series of topiramate in pediatric and adolescent migraine prophylaxis. Headache 42 (2002) 453
29. Caruso J.M., Brown W.D., Exil G., and Gascon G.G. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 40 (2000) 672-676
30. Serdaroglu G., Erhan E., Tekgul, et al. Sodium valproate prophylaxis in childhood migraine. Headache 42 (2002) 819-822
31. Miller G.S. Efficacy and safety of levetiracetam in pediatric migraine. Headache 44 (2004) 238-243
32. Belman A.L., Milazo M., and Savatic M. Gabapentin for Migraine Prophylaxis in Children. Annals of Neurology 50 Suppl 1 (2001) S109
33. Battistella P.A., Ruffilli R., Moro R., Fabiani M., Bertoli S., Antolini A., and Zacchello F. A placebo-controlled crossover trial of nimodipine in pediatric migraine. Headache 30 (1990) 264-268
34. Sorge F., and Marano E. Flunarizine v. placebo in childhood migraine. A double-blind study. Cephalalgia 5 Suppl. 2 (1985) 145-148
35. Sorge F., DeSimone R., Marano E., et al. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled crossover study. Cephalalgia 8 (1988) 1-6
36. Guidetti V., Moscato D., Ottaviano S., et al. Flunarizine and migraine in childhood an evaluation of endocrine function. Cephalalgia 7 (1987) 263-266
37. Lewis D.W., Middlebrook M.T., and Deline C. Naproxen Sodium for Chemoprophylaxis of Adolescent Migraine. Annals of Neurology 36 (1994) 542
38. Victor S., and Ryan S. Drugs for preventing migraine headaches in children. Cochrane Database System Reviews 4 (2003) CD 002761